-
PTAB invalidates Trina Solarâs TOPCon patents, ending parallel U.S. proceedings against Canadian Solar
Read more: PTAB invalidates Trina Solarâs TOPCon patents, ending parallel U.S. proceedings against Canadian SolarThe PTAB invalidated all claims of two TOPCon patents asserted by Trina Solar against Canadian Solar. The rulings effectively halt the parallel U.S. proceedings, leaving appeal as the only path forward.
-
Human lives at stake: Munich court warns against chilling effect of excessive prior art eligibility as rivaroxaban dispute heads into final round
Read more: Human lives at stake: Munich court warns against chilling effect of excessive prior art eligibility as rivaroxaban dispute heads into final roundAll other Munich landmark rulings related to access to injunctive relief, be it about SEPs, the invalidity defense to PIs, or anti-antisuit relief in different forms. The latest one is about patients more so than patents.
-
Texas jury finds SAP infringed Cyandia patents, sets stage for post-verdict fights over $17M-51M+ damages and injunction
Read more: Texas jury finds SAP infringed Cyandia patents, sets stage for post-verdict fights over $17M-51M+ damages and injunctionA Marshall, Texas jury found that SAP willfully infringed two Cyandia patents covering channel grid technology and awarded a running royalty for past damages.
-
Huaweiâs strategic planning head Emil Zhang on upping pool participation in âcriticalâ verticals
Read more: Huaweiâs strategic planning head Emil Zhang on upping pool participation in âcriticalâ verticalsHuawei believes patent pools, such as Sisvelâs point-of-sale patent programme, will fix all the legal uncertainty in critical, fragmented technology verticals, the companyâs Head of Strategic Planning & Key Projects Department told ip fray in an exclusive interview.
-
UPC Roundup (1 week): CoA grants Abbott PI after Hague denial, clarifies technicity analysis; various other decisions
Read more: UPC Roundup (1 week): CoA grants Abbott PI after Hague denial, clarifies technicity analysis; various other decisionsThis is a summary of developments in and around the Unified Patent Court (UPC) in the calendar week of April 13, 2026. It is one of our longest UPC Roundups to date. 11. Around the court 11.1 Brazil court cites UPC ruling, referencing ip fray, in Panasonic v. HMD PI decision (link to detailed article)…
-
ACTâs desire to cooperate with ETSI tests limits of FRAND policy compatibility
Read more: ACTâs desire to cooperate with ETSI tests limits of FRAND policy compatibilityACTâs planned cooperation with ETSI is putting its IPR policy compatibility standard to the test. A FRAND framework limited to specific activities may meet functional requirements, but raises questions about consistency, predictability, and the boundaries of ETSIâs approach.
-

Brazilian court enters Panasonic v. HMD PI: Via AAC pool offer was FRAND enough; UPC, German case law cited; ruling points to ip fray
Read more: Brazilian court enters Panasonic v. HMD PI: Via AAC pool offer was FRAND enough; UPC, German case law cited; ruling points to ip frayBrazilian SEP case law is evolving rapidly, and the judges in Rio de Janeiro increasingly follow developments in other jurisdictions. Occasionally they do so via ip fray.
-
Federal Circuit revives Teva’s $177M (potentially $530M) damages verdict against Eli Lilly over Emgality headache drug
Read more: Federal Circuit revives Teva’s $177M (potentially $530M) damages verdict against Eli Lilly over Emgality headache drugA $177M jury verdict, potentially tripled for willfulness, has been reinstated, and the standards for written description and enablement for genus-related patents have been clarified.


